Multiple Myeloma
Latest News in Multiple Myeloma
December 19, 2025
Highlights From the 22nd IMS Annual Meeting
Over three days, the 2025 International Myeloma Society (IMS) Annual Meeting featured dozens of new and updated clinical trial results, illustrating significant advancements in therapy from newly diagnosed (NDMM) to relapsed/refractory multiple myeloma (RRMM). Topics included real-world CAR T insights, evolving outpatient (OP) and modified bispecific antibody (bsAb) practices, expanding roles for bsAbs in NDMM and smoldering MM (SMM), tailored approaches for high-risk disease, new analyses of quadruplets, […]
December 18, 2025
ASH 2025: New Combinations Drive Advances in Multiple Myeloma – Cancer Therapy Advisor
296 Active Multiple Myeloma Clinical Trials
Source: clinicaltrials.gov
LOCATE
CLINICAL TRIALS
